EDGAR Filing Documents for 0001144204-10-051094

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-10-051094

Filing Date

2010-09-28

Accepted

2010-09-28 08:54:31

Documents

Period of Report

2010-09-30

Document Format Files

Seq	Description	Document	Type	Size
1		v197545_6-k.htm	6-K	29925
2	GRAPHIC	logo.jpg	GRAPHIC	2201
	Complete submission text file	0001144204-10-051094.txt		34491

Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989

Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 101092314
SIC: 2834 Pharmaceutical Preparations